Ethyl-eicosapentaenoic acid in bipolar  depression

descriptionPublicationkeyboard_double_arrow_right Article 01 Aug 2006 English Publisher:Royal College of PsychiatristsJournal:British Journal of Psychiatry, volume 189, pages 191-191 (issn: 0007-1250, eissn: 1472-1465,

Copyright policy )

Authors: I, Upton;

doi: 10.1192/bjp.189.2.191

pmid: 16880499

Ethyl-eicosapentaenoic acid in bipolar depression

- Summary
- Subjects
- Metrics

Abstract

Frangou et al ([2006][1]) reported ethyleicosapentaenoic acid (ethyl-EPA) to be effective in the treatment of bipolar depression. However, no mention is made of the dietary intake of ethyl-EPA among the randomised groups. Ethyl-EPA is a naturally occurring substance and hence a potential confounding

Related Organizations

Ashworth Hospital
United Kingdom
Mersey Care NHS Trust
United Kingdom

Keywords

Bipolar Disorder, Treatment Outcome, Eicosapentaenoic Acid, Humans, Antipsychotic Agents

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	5
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average